Related references
Note: Only part of the references are listed.Low testosterone levels predict clinical adverse outcomes in SARS-CoV-2 pneumonia patients
Giulia Rastrelli et al.
ANDROLOGY (2021)
Clinical symptoms of hyperandrogenic women diagnosed with COVID-19
F. A. Cadegiani et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Androgen receptor genetic variant predicts COVID-19 disease severity: a prospective longitudinal study of hospitalized COVID-19 male patients
J. Mccoy et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia
J. McCoy et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)
Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males
Margherita Baldassarri et al.
EBIOMEDICINE (2021)
Sex differences in COVID-19: the role of androgens in disease severity and progression
Mohamed S. Mohamed et al.
ENDOCRINE (2021)
Androgen sensitivity gateway to COVID-19 disease severity
Carlos Gustavo Wambier et al.
DRUG DEVELOPMENT RESEARCH (2020)
Perspective: COVID-19, implications of nasal diseases and consequences for their management
Li Jian et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Hydroxychloroquine and COVID-19
Neeraj Sinha et al.
POSTGRADUATE MEDICAL JOURNAL (2020)
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity
Andy Goren et al.
JOURNAL OF COSMETIC DERMATOLOGY (2020)
Racial variations in COVID-19 deaths may be due to androgen receptor genetic variants associated with prostate cancer and androgenetic alopecia. Are anti-androgens a potential treatment for COVID-19?
John McCoy et al.
JOURNAL OF COSMETIC DERMATOLOGY (2020)
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The Gabrin sign
Carlos Gustavo Wambier et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents A Systematic Review
Riccardo Castagnoli et al.
JAMA PEDIATRICS (2020)
Male balding is a major risk factor for severe COVID-19
Justin Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID-19: An Open-Label Randomized Controlled Pilot Study
Ting Li et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2020)
Alopecia and grey hair are associated with COVID-19 Severity
Paulo Muller Ramos et al.
EXPERIMENTAL DERMATOLOGY (2020)
Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men
A. Goren et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
The Efficacy of the Mineralcorticoid Receptor Antagonist Canrenone in COVID-19 Patients
Marco Vicenzi et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
Khalil Ansarin et al.
BIOIMPACTS (2020)
Androgen deprivation therapy may constitute a more effective COVID-19 prophylactic than therapeutic strategy
N. N. Bennani et al.
ANNALS OF ONCOLOGY (2020)
Sex-Based Differences in Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Infection
Rudragouda Channappanavar et al.
JOURNAL OF IMMUNOLOGY (2017)
Testosterone deficiency in the aging male
J. Abram McBride et al.
THERAPEUTIC ADVANCES IN UROLOGY (2016)
Negative Association between Testosterone Concentration and Inflammatory Markers in Young Men: A Nested Cross-Sectional Study
Johannes Bobjer et al.
PLOS ONE (2013)
Androgen receptor and androgen-dependent gene expression in lung
Laura Mikkonen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
Phenotypic heterogeneity of mutations in androgen receptor gene
Singh Rajender et al.
ASIAN JOURNAL OF ANDROLOGY (2007)
International Union of Pharmacology. LXV. The pharmacology and classification of the nuclear receptor superfamily: Glucocorticoid, mineralocorticoid, progesterone, and androgen receptors
Nick Z. Lu et al.
PHARMACOLOGICAL REVIEWS (2006)
Share Paper
